Following positive trial results, retatrutide, a novel peptide therapy for managing adult-onset metabolic disorder, has received regulatory approval from Great Britain's Drug and Products Agency ( MHRA https://agneszsxm586651.blogzet.com/retatrutide-medication-peptide-british-authorization-and-launch-55988251